Excision or curettage of a bone cyst or benign tumor of the humerus with allograft reconstruction
Verified May 8, 2026 · 5 sources ↓
- Medicare
- $797.95
- Total RVUs
- 23.89
- Global, days
- 90
- Region
- Elbow
Documentation requirements
What must appear in the operative or office note to support the claim.
Source · Editorial brief grounded in 5 cited references ↓
- Specify the lesion type (bone cyst vs. benign tumor) and its location on the humerus (proximal, diaphyseal, distal)
- Confirm use of allograft, not autograft — operative note must name the graft source and type (e.g., cancellous allograft, structural allograft)
- Document lesion dimensions and extent of osseous defect requiring reconstruction
- Record approach used and any osteotomy performed for exposure (e.g., olecranon osteotomy for distal humeral access)
- Include pathology submission confirmation or intraoperative gross description supporting benign characterization
- Note any fixation hardware placed if structural allograft required stabilization
Applicable modifiers
Modifiers commonly billed with this code.
Source · AMA CPT modifier descriptors · CMS NCCI Policy Manual
What this code covers
Source · Editorial summary grounded in 5 cited references ↓
CPT 24116 covers surgical removal or curettage of a bone cyst or benign tumor of the humerus combined with allograft bone graft placement to fill the resulting defect. The allograft component is what distinguishes this code from 24110 (excision without grafting) and 24115 (excision with autograft). Using the wrong code in that trio is the most common coding error on these cases.
The 90-day global period covers all routine post-op care through day 90, including wound checks, cast or splint changes, and imaging that's part of routine follow-up. Any E/M visit for a new or unrelated problem during that window requires modifier 24. A staged or planned second procedure within the global needs modifier 58.
This procedure carries a meaningful facility vs. non-facility rate differential — see the Site of Service comparison on this page. When performed at an ASC vs. HOPD, the payment difference is substantial and drives prior authorization strategy for many commercial payers.
RVU & reimbursement
Component RVUs and Medicare national rate. Actual payment varies by GPCI locality.
Source · CMS Physician Fee Schedule, RVU26A · January 2026
| Work RVU | 11.92 |
| Practice expense RVU | 9.43 |
| Malpractice RVU | 2.54 |
| Total RVU | 23.89 |
| Medicare national rate | $797.95 |
| Global period | 90 days |
Payment by site of service
Medicare pays different rates by setting. HOPD typically pays substantially more than ASC for the same procedure.
Source · CMS OPPS Addendum B·ASC HCPCS payment rates·2026
| Setting | Medicare rate (national) |
|---|---|
Office (PFS non-facility) Procedure performed in physician's office | $797.95 |
HOPD (APC 5114) Hospital outpatient department | $7,413.38 |
ASC (PI J8) Ambulatory surgical center (freestanding) | $4,682.29 |
Common denial reasons
The recurring reasons claims for CPT 24116 get rejected.
Source · Editorial brief grounded in CMS NCCI edits, AAOS coding appeals, and cited references ↓
- Upcoding flag when 24110 (no graft) or 24115 (autograft) better matches the operative note — payers audit graft source language
- Missing allograft documentation: if the op note doesn't explicitly name the allograft, payers default to downcode to 24110
- Medical necessity denial when pre-op imaging or pathology report is absent from the claim record
- Bundling conflict if 24105 (olecranon bursa excision) or other elbow codes are billed same-day without modifier 59 or XS
- Global period violation when routine post-op visit is billed without modifier 24 during the 90-day window
Frequently asked questions
Source · Generated from the editorial pipeline, verified against 5 cited references ↓
01What's the difference between 24110, 24115, and 24116?
02Can I bill separately for the allograft material with 24116?
03If an olecranon osteotomy was performed for exposure, does that get billed separately?
04Is modifier 62 (co-surgery) appropriate for 24116?
05What does the 90-day global period cover for this case?
06Is prior authorization typically required for 24116?
Sources & references
Editorial content was developed using the following public sources. Last verified May 8, 2026.
- 01CMS Physician Fee Schedule 2026
- 02cms.govhttps://www.cms.gov/files/document/2025nccimedicarepolicymanualcompletepdf.pdf
- 03bedrockbilling.comhttps://bedrockbilling.com/static/cci/24116
- 04aaos.orghttps://www.aaos.org/education/about-aaos-products/coding-resources/
- 05aoassn.orghttps://www.aoassn.org/wp-content/uploads/2020/12/CodingTTP.pdf
Mira AI Scribe
Mira's AI scribe captures the lesion type, anatomic location on the humerus, graft type (allograft confirmed), defect dimensions, and surgical approach directly from dictation. This prevents the most common audit flag on 24116: an op note that describes the procedure but fails to explicitly document allograft use, which triggers a downcode to 24110 on review.
See how Mira captures CPT 24116 documentation